BP components in advanced CKD and the competing risks of death, ESRD, and cardiovascular events

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 6, 2015, Pages 911-913

  Sinha, Arjun D ^a   Agarwal, Rajiv ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; PYRIDOXINE;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; EDITORIAL; END STAGE RENAL DISEASE; HEART INFARCTION; HEMODIALYSIS; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; LIMB AMPUTATION; MORTALITY; MULTICENTER STUDY (TOPIC); PULSE WAVE; RANDOMIZED CONTROLLED TRIAL (TOPIC); CARDIOVASCULAR DISEASES; FEMALE; MALE; RENAL INSUFFICIENCY, CHRONIC;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84930466531     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04300415     Document Type: Editorial

References (14)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
3. Palit S, Chonchol M, Cheung AK, Kaufman J, Smits G, Kendrick J: Association of BP with death, cardiovascular events, and progression to chronic dialysis in patients with advanced kidney disease. Clin J Am Soc Nephrol 10: 934-940, 2015
4. Jamison RL, Hartigan P, Kaufman JS, Goldfarb DS, Warren SR, Guarino PD, Gaziano JM; Veterans Affairs Site Investigators: Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: A randomized controlled trial. JAMA 298: 1163-1170, 2007
5. Anderson AH, YangW, Townsend RR, PanQ, Chertow GM, Kusek JW, Charleston J,He J, KallemR, Lash JP, Miller ER 3rd, RahmanM, Steigerwalt S, Weir M, Wright JT Jr., Feldman HI; Chronic Renal Insufficiency Cohort Study Investigators: Time-updated systolic blood pressure and the progression of chronic kidney disease: A cohort study. Ann Intern Med 162: 258-265, 2015
6. Agarwal R, Andersen MJ: Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease. Kidney Int 69: 406-411, 2006
7. Agarwal R, Andersen MJ: Blood pressure recordings within and outside the clinic and cardiovascular events in chronic kidney disease. Am J Nephrol 26: 503-510, 2006
8. Agarwal R, Bunaye Z, Bekele DM, Light RP: Competing risk factor analysis of end-stage renal disease and mortality in chronic kidney disease. Am J Nephrol 28: 569-575, 2008
9. Klahr S, Levey AS, BeckGJ, Caggiula AW,Hunsicker L, Kusek JW, Striker G; Modification of Diet in Renal Disease Study Group: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330: 877-884, 1994
10. Wright JT Jr., BakrisG,Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD,Middleton JP, Rostand SG; African American Study of Kidney Disease and Hypertension StudyGroup: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA 288: 2421-2431, 2002
11. Norris K, Bourgoigne J,Gassman J, Hebert L, Middleton J, Phillips RA, Randall O, Rostand S, Sherer S, Toto RD,Wright JT Jr.,Wang X, Greene T, Appel LJ, Lewis J; AASK Study Group: Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Am J Kidney Dis 48: 739-751, 2006
12. Ruggenenti P, Perna A, Loriga G, Ganeva M, Ene-Iordache B, Turturro M, Lesti M, Perticucci E, Chakarski IN, Leonardis D, Garini G, Sessa A, Basile C, Alpa M, Scanziani R, Sorba G, Zoccali C, Remuzzi G; REIN-2 Study Group: Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): Multicentre, randomised controlled trial. Lancet 365: 939-946, 2005
13. Upadhyay A, Earley A, Haynes SM, Uhlig K: Systematic review: Blood pressure target in chronic kidney disease and proteinuria as an effect modifier. Ann Intern Med 154: 541-548, 2011
14. Ninomiya T, Perkovic V, Turnbull F, Neal B, Barzi F, Cass A, Baigent C, Chalmers J, Li N,Woodward M, MacMahon S; Blood Pressure Lowering Treatment Trialists' Collaboration: Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: Meta-analysis of randomised controlled trials. BMJ 347: f5680, 2013